Skip to main content
Top
Published in: Obesity Surgery 4/2021

01-04-2021 | Sleeve Gastrectomy | Original Contributions

Prediction of Long-Term Diabetes Remission After Metabolic Surgery in Obese East Asian Patients: a Comparison Between ABCD and IMS Scores

Authors: Masayuki Ohta, Yosuke Seki, Tetsuji Ohyama, Rixing Bai, Sang Hyun Kim, Takashi Oshiro, Tao Jiang, Akira Sasaki, Takeshi Naitoh, Tsuyoshi Yamaguchi, Susumu Inamine, Yasuhiro Miyazaki, Soo Min Ahn, Yoonseok Heo, Hui Liang, Seung Ho Choi, Wah Yang, Qiyuan Yao, Kentaro Inoue, Hiroshi Yamamoto, Hyuk-Joon Lee, Young Suk Park, Tae Kyung Ha, Seung-Wan Ryu, Cunchuan Wang, Sungsoo Park, Kazunori Kasama

Published in: Obesity Surgery | Issue 4/2021

Login to get access

Abstract

Purpose

Recently, more than 10 models have been developed to predict remission of type 2 diabetes mellitus (T2DM) after metabolic surgery. The ABCD score was compared to the individualized metabolic surgery (IMS) score in terms of prediction of T2DM remission, but which of the two scoring systems is better remains controversial.

Methods

Patient data from 463 obese East Asian patients who underwent laparoscopic Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), or SG with duodenojejunal bypass (SG-DJB) as a primary operation and were followed for at least 3 years were retrospectively collected from 24 institutions. The correlation between the ABCD and IMS scoring systems and the discrimination power of the models was evaluated. The cut-off point for the IMS stage of T2DM severity was also revised to adjust the scoring system to obese East Asian patients.

Results

The two scoring systems were significantly well correlated. The IMS scoring system showed significant differences in T2DM remission rates between the procedures in the moderate stage, but the ABCD score showed no significant differences in each category. The discrimination power of the IMS score was comparable to that of the ABCD score at both 3 and 5 years. The revised IMS scoring system showed that SG-DJB had significantly higher T2DM remission rates in the moderate stage at 5 years than RYGB or SG.

Conclusion

IMS score may be comparable to ABCD score to predict T2DM remission in obese East Asian patients. The revised IMS scoring system may also select candidates for SG or SG-DJB.
Literature
2.
go back to reference Lee WJ, Hur K, Wong S, et al. Metabolic surgery ABCD score: predicting the success of surgical treatment diabetes. Obes Surg. 2013;23:1020.CrossRef Lee WJ, Hur K, Wong S, et al. Metabolic surgery ABCD score: predicting the success of surgical treatment diabetes. Obes Surg. 2013;23:1020.CrossRef
17.
go back to reference Zachariah PJ, Chen CY, Lee WJ, et al. Compared to sleeve gastrectomy, duodenal-jejunal bypass with sleeve gastrectomy gives better glycemic control in T2DM patients, with lower β-cell response and similar appetite sensations: mixed-meal study. Obes Surg. 2016;26:2862–72.CrossRef Zachariah PJ, Chen CY, Lee WJ, et al. Compared to sleeve gastrectomy, duodenal-jejunal bypass with sleeve gastrectomy gives better glycemic control in T2DM patients, with lower β-cell response and similar appetite sensations: mixed-meal study. Obes Surg. 2016;26:2862–72.CrossRef
Metadata
Title
Prediction of Long-Term Diabetes Remission After Metabolic Surgery in Obese East Asian Patients: a Comparison Between ABCD and IMS Scores
Authors
Masayuki Ohta
Yosuke Seki
Tetsuji Ohyama
Rixing Bai
Sang Hyun Kim
Takashi Oshiro
Tao Jiang
Akira Sasaki
Takeshi Naitoh
Tsuyoshi Yamaguchi
Susumu Inamine
Yasuhiro Miyazaki
Soo Min Ahn
Yoonseok Heo
Hui Liang
Seung Ho Choi
Wah Yang
Qiyuan Yao
Kentaro Inoue
Hiroshi Yamamoto
Hyuk-Joon Lee
Young Suk Park
Tae Kyung Ha
Seung-Wan Ryu
Cunchuan Wang
Sungsoo Park
Kazunori Kasama
Publication date
01-04-2021
Publisher
Springer US
Published in
Obesity Surgery / Issue 4/2021
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-05151-6

Other articles of this Issue 4/2021

Obesity Surgery 4/2021 Go to the issue